Decoding Diagnostic Test Results with Genova Diagnostics

episode

Wild Health Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded21 Dec 2022

Publisherwildhealth.libsyn.com ↗

Handlerec:8526430

Show notes

In this episode of the podcast, Dr. Erin Donaldson hosts Michael Chapman, Director of Product Innovation, and Patti Devers, Chief Clinical Officer, of Genova Diagnostics. This global, clinical laboratory is pioneering a system-based approach that supports healthcare providers in personalizing treatment and prevention of chronic disease. Together, they discuss the specifics of Genova's diagnostics tests – for gut health, methylation, nutrient deficiencies, and more – and the key biomarkers that have major implications on our health and disease risk.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in